Immunotherapy, chemotherapy and stereotactic radiotherapy to metastases, followed by definitive surgery or radiotherapy to the primary tumour, in patients with synchronous oligo-metastatic NSCLC: The ETOP CHESS trial

dc.conference.dateSEP 19-OCT 18, 2020
dc.conference.titleESMO Virtual Congress
dc.contributor.authorGuckenberger, M.
dc.contributor.authorOpitz, I.
dc.contributor.authorDafni, U.
dc.contributor.authorFontecedro, A. Curioni
dc.contributor.authorScherz, A.
dc.contributor.authorElicin, O.
dc.contributor.authorAddeo, A.
dc.contributor.authorAerts, J. G. J. V.
dc.contributor.authorDingemans, A-M.
dc.contributor.authorHendriks, L.
dc.contributor.authorJimenez Munarriz, B.
dc.contributor.authorJuan-Vidal, O.
dc.contributor.authorSullivan, I.
dc.contributor.authorValdivia, J.
dc.contributor.authorPiguet, A-C.
dc.contributor.authorRoschitzki-Voser, H.
dc.contributor.authorEhrbar, S.
dc.contributor.authorBaumgartl, M.
dc.contributor.authorPeters, S.
dc.contributor.authorStahel, R. A.
dc.contributor.authoraffiliation[Guckenberger, M.] Univ Hosp Zurich, Dept Radiat Oncol, Zurich, Switzerland
dc.contributor.authoraffiliation[Ehrbar, S.] Univ Hosp Zurich, Dept Radiat Oncol, Zurich, Switzerland
dc.contributor.authoraffiliation[Baumgartl, M.] Univ Hosp Zurich, Dept Radiat Oncol, Zurich, Switzerland
dc.contributor.authoraffiliation[Opitz, I.] Univ Hosp Zurich, Dept Thorac Surg, Zurich, Switzerland
dc.contributor.authoraffiliation[Dafni, U.] Natl & Kapodistrian Univ Athens NKUA, Sch Hlth Sci, Athens, Attica, Greece
dc.contributor.authoraffiliation[Dafni, U.] Frontier Sci Fdn Hellas, Athens, Attica, Greece
dc.contributor.authoraffiliation[Fontecedro, A. Curioni] Univ Hosp Zurich, Dept Med Oncol & Haematol, Zurich, Switzerland
dc.contributor.authoraffiliation[Stahel, R. A.] Univ Hosp Zurich, Dept Med Oncol & Haematol, Zurich, Switzerland
dc.contributor.authoraffiliation[Scherz, A.] Univ Hosp Bern, Inselspital, Dept Med Oncol, Bern, Switzerland
dc.contributor.authoraffiliation[Elicin, O.] Univ Hosp Bern, Inselspital, Dept Radiat Oncol, Bern, Switzerland
dc.contributor.authoraffiliation[Addeo, A.] Univ Hosp Geneva, Dept Med Oncol & Haematol, Geneva, Switzerland
dc.contributor.authoraffiliation[Aerts, J. G. J. V.] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands
dc.contributor.authoraffiliation[Dingemans, A-M.] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands
dc.contributor.authoraffiliation[Hendriks, L.] Maastricht Univ, Med Ctr, Dept Pulm Dis, Maastricht, Netherlands
dc.contributor.authoraffiliation[Jimenez Munarriz, B.] Hosp HM Sanchinarro, Ctr Integral Oncol Clara Campal, Madrid, Spain
dc.contributor.authoraffiliation[Juan-Vidal, O.] Hosp Univ Politecn La Fe, Valencia, Spain
dc.contributor.authoraffiliation[Sullivan, I.] Hosp Santa Creu & Sant Pau, Barcelona, Spain
dc.contributor.authoraffiliation[Valdivia, J.] Virgen de las Nieves Univ Hosp, Integral Oncol Div, Granada, Spain
dc.contributor.authoraffiliation[Piguet, A-C.] European Thorac Oncol Platform ETOP, Coordinating Off, Bern, Switzerland
dc.contributor.authoraffiliation[Roschitzki-Voser, H.] European Thorac Oncol Platform ETOP, Coordinating Off, Bern, Switzerland
dc.contributor.authoraffiliation[Peters, S.] Ctr Hosp Univ Vaudois CHUV, Dept Oncol, Lausanne, Switzerland
dc.contributor.funderAstraZeneca
dc.date.accessioned2025-01-07T14:15:49Z
dc.date.available2025-01-07T14:15:49Z
dc.date.issued2020-09-01
dc.identifier.doi10.1016/j.annonc.2020.08.1731
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753420417272/pdf
dc.identifier.urihttps://hdl.handle.net/10668/26249
dc.identifier.wosID573469102010
dc.issue.number4
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.page.numberS895-S896
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleImmunotherapy, chemotherapy and stereotactic radiotherapy to metastases, followed by definitive surgery or radiotherapy to the primary tumour, in patients with synchronous oligo-metastatic NSCLC: The ETOP CHESS trial
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number31
dc.wostypeMeeting Abstract

Files